MAKO Surgical Says Will Start Offering Stock
MAKO Surgical Corp. (Nasdaq: MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. is acting as the sole manager for the offering.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.